Affiliation:
1. Department of Clinical Medicine and Surgery, Division of Minimally Invasive and Robotic Hepato‐Pancreato‐Biliary Surgery, and Transplantation Service Federico II University Hospital Naples Italy
2. Department of Surgery, Division of Hepato‐Pancreato‐Biliary Surgery Seoul National University Bundang Hospital Seongnam South Korea
Abstract
AbstractBackgroundThere is still little knowledge about the outcomes of laparoscopic liver resection (LLR) for multiple hepatocellular carcinomas (HCC). The aim of this study was to assess the short‐ and long‐ term outcomes of LLR versus open liver resection (OLR) for patients with multiple HCC within and beyond the Milan criteria, and in both BCLC‐A and ‐B stage.MethodsData regarding all consecutive patients undergoing liver resection for multiple HCC were retrospectively collected from Asian (South Korean) and European (Italian) referral HPB centers. The cases were propensity‐score matched for age, BMI, center, extent of the resection, postero‐superior location of the lesion, underlying liver condition, BCLB staging and the Milan criteria.ResultsA total of 203 patients were included in the study: 27% of patients had undergone hemi‐hepatectomy, 26.6% atypical resections, 20.6% sectionectomy and 16.2% segmentectomy. After PSM two cohorts of 57 patients were obtained, with no significant differences in all preoperative characteristics. The length of hospital stay was significantly lower after LLR (median 7 vs. 9 days, p < .01), with no statistically significant differences in estimated blood loss, operation time, transfusions, postoperative bile leak, ascites, severe complications and R1 resection rates. After a median follow‐up of 61 (±7) months, there were no significant differences between OLR and LLR in both median OS (69 vs. 59 months, p = .74, respectively) and median DFS (12 vs. 10 months, p = .48, respectively).ConclusionLLR for multiple HCC can be safe and effective in selected cases and is able to shorten median hospital stay without affecting perioperative and long‐term oncological outcomes.